This is a revision of a previously submitted proposal to study peptide-HLA Class II interactions. Both promiscuous and allele-specific peptide-Class II interactions will be studied, particularly with respect to competition by alleles for promiscuous peptides and the influence of neighboring peptides upon the function of another peptide. The influence of the microenvironment within the cell upon the formation of peptide-Class II complexes will also be studied. For allele-specific peptides, the investigators will test whether linked allele-specific epitopes can lead to cryptic determinants during antigen processing. The investigators have now adapted their system to a more """"""""natural"""""""" one of binding of exogenously administered peptides to living cells, rather than to purified Class II molecules as in their previous application. Their measurements of binding are 1) through proliferation of a T cell clone specific for the antigen and 2) direct visualization after isolation of Class II molecules bound to the peptide.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI038913-02
Application #
2442677
Study Section
Experimental Immunology Study Section (EI)
Project Start
1996-07-15
Project End
1999-06-30
Budget Start
1997-07-01
Budget End
1998-06-30
Support Year
2
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Benaroya Research Institute at Virginia Mason
Department
Type
DUNS #
City
Seattle
State
WA
Country
United States
Zip Code
98101
Reijonen, H; Elliott, J F; van Endert, P et al. (1999) Differential presentation of glutamic acid decarboxylase 65 (GAD65) T cell epitopes among HLA-DRB1*0401-positive individuals. J Immunol 163:1674-81
Hershberg, R M; Cho, D H; Youakim, A et al. (1998) Highly polarized HLA class II antigen processing and presentation by human intestinal epithelial cells. J Clin Invest 102:792-803
Hershberg, R M; Framson, P E; Cho, D H et al. (1997) Intestinal epithelial cells use two distinct pathways for HLA class II antigen processing. J Clin Invest 100:204-15